UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting the epidermal growth factor receptor

British journal of cancer, 2004-08, Vol.91 (3), p.418-424

2004

Volltextzugriff (PDF)

Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis

Carcinogenesis (New York), 2014-05, Vol.35 (5), p.967-973

2014

Volltextzugriff (PDF)

A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)

Annals of oncology, 2018-06, Vol.29, p.v103-v103

2018

Volltextzugriff (PDF)

Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic tumors of pancreatobiliary origin

Journal of vascular and interventional radiology, 2016-03, Vol.27 (3), p.S62-S62

2016

Volltextzugriff (PDF)

A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)

Annals of oncology, 2017-06, Vol.28, p.iii150-iii150

2017

Volltextzugriff (PDF)

Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Annals of oncology, 2018-10, Vol.29, p.viii433-viii433

2018

Volltextzugriff (PDF)

Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Annals of oncology, 2018-10, Vol.29, p.viii42-viii42

2018

Volltextzugriff (PDF)

PD-019ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii109-ii109

2016

Volltextzugriff (PDF)

Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045)

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S106-S107

2016

Volltextzugriff (PDF)

Survival trends in unresectable hepatocellular carcinoma and the effect of DEB-TACE: surveillance, epidemiology and end results database vs. tertiary cancer center

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S25-S26

2014

Volltextzugriff (PDF)

Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma and the effect of resin-based Yttrium-90 radioembolization: surveillance, epidemiology and end results database vs. tertiary cancer center

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S103-S104

2014

Volltextzugriff (PDF)

Prospective open-label single center study of safety and efficacy of glass-based Y90 radioembolization for infiltrative HCC with PVT

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S90-S90

2014

Volltextzugriff (PDF)

Developments in the Systemic Therapy of Pancreatic Cancer

Cancer investigation, 2003, Vol.21 (1), p.73-86

2003

Volltextzugriff (PDF)

The therapeutic dilemma of BCLC C hepatocellular carcinoma (HCC): an interventional oncology-based approach

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S176-S176

2013

Volltextzugriff (PDF)

Survivals and predictive factors of metastatic hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S170-S171

2013

Volltextzugriff (PDF)

Survivals and predictive factors of atypical unresectable hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S173-S174

2013

Volltextzugriff (PDF)

Longitudinal quality of life assessment of patients with hepatic metastatic colorectal adenocarcinoma after treatment with transarterial radioembolization Yttrium-90 therapy

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S37-S37

2013

Volltextzugriff (PDF)

Resin-based Yttrium-90 radioembolization for metastatic neuroendocrine tumors in a single-center cancer registry

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S36-S36

2013

Volltextzugriff (PDF)

A Synthetic Lethal Screen Identifies Genes That Mediate Gemcitabine Resistance in Pancreatic Cancer

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S88-S88

2012

Volltextzugriff (PDF)

Broad targeting of angiogenesis for cancer prevention and therapy

Seminars in cancer biology, 2015-12, Vol.35 (Suppl), p.S224-S243

2015

Volltextzugriff (PDF)

Update with longitudinal analysis of quality of life assessment after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC)

Journal of vascular and interventional radiology, 2013-07, Vol.24 (7), p.1082-1082

2013

Volltextzugriff (PDF)

Analysis of liver-directed therapies in U.S. cancer patients

Current oncology (Toronto), 2015-12, Vol.22 (6), p.e457-461

2015

Volltextzugriff (PDF)

A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer

HPB (Oxford, England), 2016-04, Vol.18, p.e342-e343

2016

Volltextzugriff (PDF)

Doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC): Survival outcomes and factors predicting survival outcomes in a 366-patient cohort

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S67-S67

2013

Volltextzugriff (PDF)

Quality of life assessment after radiofrequency ablation (RFA) in patients with malignant liver tumors

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S147-S148

2013

Volltextzugriff (PDF)

1 – 25 von 288

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(273)
Mit Volltextzugriff
(230)

Publikationsform

Artikel
(285)
Buchkapitel
(3)

Sprache

Englisch
(288)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(85)
Oncology
(72)
Humans
(49)
Radiology
(23)
Female
(22)
Tumors
(21)
Animals
(18)
Cancer
(16)
Chemotherapy
(15)
Pancreatic Cancer
(15)
Biological And Medical Sciences
(13)
Cell Line, Tumor
(13)
Colorectal Cancer
(13)
Male
(12)
Medical Sciences
(12)
Mice
(12)
Pancreatic Neoplasms - Drug Therapy
(12)
Middle Aged
(11)
Cancer Research
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Targeting the epidermal growth factor receptor

Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis

A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)

Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic tumors of pancreatobiliary origin

A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)

Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO)

PD-019ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045)

Survival trends in unresectable hepatocellular carcinoma and the effect of DEB-TACE: surveillance, epidemiology and end results database vs. tertiary cancer center

Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma and the effect of resin-based Yttrium-90 radioembolization: surveillance, epidemiology and end results database vs. tertiary cancer center

Prospective open-label single center study of safety and efficacy of glass-based Y90 radioembolization for infiltrative HCC with PVT

Developments in the Systemic Therapy of Pancreatic Cancer

The therapeutic dilemma of BCLC C hepatocellular carcinoma (HCC): an interventional oncology-based approach

Survivals and predictive factors of metastatic hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

Survivals and predictive factors of atypical unresectable hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

Longitudinal quality of life assessment of patients with hepatic metastatic colorectal adenocarcinoma after treatment with transarterial radioembolization Yttrium-90 therapy

Resin-based Yttrium-90 radioembolization for metastatic neuroendocrine tumors in a single-center cancer registry

A Synthetic Lethal Screen Identifies Genes That Mediate Gemcitabine Resistance in Pancreatic Cancer

Broad targeting of angiogenesis for cancer prevention and therapy

Update with longitudinal analysis of quality of life assessment after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC)

Analysis of liver-directed therapies in U.S. cancer patients

A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer

Doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC): Survival outcomes and factors predicting survival outcomes in a 366-patient cohort

Quality of life assessment after radiofrequency ablation (RFA) in patients with malignant liver tumors

Aktive Filter

Suchergebnisse filtern